Parasite immunomodulatory role in reducing the prevalence of COVID-19 in endemic regions
Open Access
- 7 April 2022
- journal article
- review article
- Published by Universa Medicina in Universa Medicina
- Vol. 41 (1), 90-99
- https://doi.org/10.18051/univmed.2022.v41.90-99
Abstract
Nearly 35 million cases and one million deaths over the nine months of the COVID-19 pandemic have been reported worldwide. Africa and some countries with endemic parasitic infections had a low incidence of COVID-19. By contrast, the United States and several European countries, having a non-endemicity of parasitic infections, recorded a high incidence of COVID-19. Some parasites have an immunomodulatory mechanism that can induce an immune tolerance state in the infected persons by balancing pro-inflammatory and anti-inflammatory responses. Emerging reports also stated that COVID-19 and helminth co-infections may have more hidden outcomes than predictable ones. Hence, the aim of this literature review is to show and identify that an increase in the number of regulatory immune cells due to the immunomodulatory role of a pre-existing parasitic infection could reduce the risk of COVID-19. This study explored the existing literature to determine the role of parasitic infections in modulating the immune response and possibly reduce the risk of COVID-19 infection in endemic countries. The mechanism of immunomodulation by parasites is the increased numbers of Treg cells, M2 macrophages, eosinophils, the Th2 cytokines IL-4 and IL-5, and the pro-inflammatory downregulation of IFN λ, TNF α, and IL-6, which play an essential role in inducing cytokine storms in COVID-19 infection. This condition will probably occur in an individual with parasitic infection in a community with limited facilities and infrastructure to treat parasitic infections, particularly in developing countries. To conclude, in endemic areas, the immunomodulatory effect of parasitic infection to reduce the risk of COVID-19 cases/deaths is a possibility if the host is immunocompetent. Herein, the current knowledge on the immunomodulatory role of COVID-19 and helminth co-infections will be discussed.Keywords
This publication has 36 references indexed in Scilit:
- World Health Organization Estimates of the Global and Regional Disease Burden of 11 Foodborne Parasitic Diseases, 2010: A Data SynthesisPLoS Medicine, 2015
- Investing in health systems for universal health coverage in AfricaBMC International Health and Human Rights, 2014
- Autoimmunity, phospholipid-reacting antibodies and malaria immunityLupus, 2014
- Do you see what I see: Recognition of protozoan parasites by Toll-like receptorsCurrent Immunology Reviews, 2014
- Incidence and prevalence of Toxoplasma gondii infection in women in France, 1980–2020: model-based estimationEpidemiology and Infection, 2013
- Update on the Mapping of Prevalence and Intensity of Infection for Soil-Transmitted Helminth Infections in Latin America and the Caribbean: A Call for ActionPLoS Neglected Tropical Diseases, 2013
- Immunomodulatory effects of helminths and protozoa in multiple sclerosis and experimental autoimmune encephalomyelitisParasite Immunology, 2013
- Introduction to Syndemics: A Critical Systems Approach to Public and Community Health by Merrill SingerMedical Anthropology Quarterly, 2012
- Immune defence, parasite evasion strategies and their relevance for ‘macroscopic phenomena’ such as virulencePhilosophical Transactions B, 2008
- Protective immune mechanisms in helminth infectionNature Reviews Immunology, 2007